AI Innovations Amid COVID-19

July 03, 2020

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

NACDS: Electronic Prescriptions for Controlled Substances Should be Mandatory

July 02, 2020

NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.

New Machine Learning Tool Can Predict Adverse Drug Effects

June 29, 2020

A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.

FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD

June 17, 2020

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

FDA OKs FreeStyle Libre 2 System for Adults and Children With Diabetes

June 15, 2020

Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.

ADA 2020: FreeStyle Libre System Use Decreases Diabetic Ketoacidosis Rates

June 13, 2020

New findings from a study presented at the ADA’s 80th Scientific Sessions showed a dramatic drop in diabetic ketoacidosis hospitalizations in patients who used the FreeStyle Libre system

Technology-Enhanced Insulin Education by Pharmacists Prior to Hospital Discharge Boosts Patient Confidence

June 13, 2020

A poster presented at ADA’s 80th Scientific Sessions examines the effects of interactive pharmacist insulin teaching for patients with diabetes prior to hospital discharge.

Telehealth Program Enhances Engagement, Glycemic Control in Rural Patients With Diabetes

June 13, 2020

Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.

New Apps Tap Into Unmet Need for COVID-19 Testing in the US

June 11, 2020

Syndromic surveillance apps may be key in providing solutions to limitations on current COVID-19 case projection data collection efforts.

COVID-19 and Telemedicine: A Conversation

May 26, 2020

In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.